Cargando…
Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers
Tumor cells that are nonsensitive to anticancer drugs frequently have a multidrug resistant (MDR) phenotype. Many studies with cell lines and patient material have been done to investigate the impact of different resistance markers at protein and mRNA level in drug resistance but with contradictory...
Autores principales: | Rolff, Jana, Dorn, Cornelia, Merk, Johannes, Fichtner, Iduna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696640/ https://www.ncbi.nlm.nih.gov/pubmed/19547715 http://dx.doi.org/10.1155/2009/814140 |
Ejemplares similares
-
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance
por: Grasse, Sabrina, et al.
Publicado: (2018) -
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine
por: Rivera, Maria, et al.
Publicado: (2020) -
Occurrence of a multidrug-resistant phenotype in human lung xenografts.
por: Mattern, J., et al.
Publicado: (1987) -
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
por: Alcaniz, Joshua, et al.
Publicado: (2023) -
Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation
por: Dahlmann, Mathias, et al.
Publicado: (2012)